Biomerics Launches Interventional Medical Plastics Division with Acquisition of Dependable Plastics
SALT LAKE CITY, July 11, 2022 /PRNewswire/ -- Biomerics, the leading vertically integrated medical device contract manufacturer in the interventional device market, announced the acquisition of Dependable Plastics and creation of a new division -- Biomerics Interventional Medical Plastics (IMP) Division.
- SALT LAKE CITY, July 11, 2022 /PRNewswire/ -- Biomerics, the leading vertically integrated medical device contract manufacturer in the interventional device market, announced the acquisition of Dependable Plastics and creation of a new division -- Biomerics Interventional Medical Plastics (IMP) Division.
- These capabilities, combined with Biomerics injection molding operations, will make Biomerics IMP a full-service plastics component supplier to the interventional markets.
- "In support of our leading customers, Biomerics is excited to launch our Interventional Medical Plastics Division," stated Travis Sessions, CEO of Biomerics.
- Travis Sessions concluded, "The Biomerics IMP Division was created to integrate Biomerics' various plastics manufacturing component technologies to enable rapid design, development, and manufacture of plastics components for the robotic and interventional markets.